Noninferiority Margins in Clinical Trials-A Moving Target?

被引：0
|
作者：
Wang, Li [1 ]
Torguson, Rebecca [1 ]
Farb, Andrew [1 ,2 ]
机构：
[1] US FDA, Off Prod Evaluat & Qual, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA
[2] US FDA, Ctr Devices & Radiol Hlth, Off Cardiovasc Devices, 10903 New Hampshire Ave,16 WO66-2312, Silver Spring, MD 20993 USA
来源：
JAMA CARDIOLOGY | 2022年 / 7卷 / 03期
关键词：
CORONARY INTERVENTION TRIALS; END-POINT DEFINITIONS;
D O I：
10.1001/jamacardio.2021.5733
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：327 / 329
页数：4
相关论文
共 50 条
  • [1] Interpreting the results of noninferiority trials-a review
    Cuzick, Jack
    Sasieni, Peter
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1755 - 1759
  • [2] A systematic review of noninferiority margins in oncology clinical trials
    Hashim, Mahmoud
    Vincken, Talitha
    Kroi, Florint
    Gebregergish, Samron
    Spencer, Mike
    Wang, Jianping
    Kampfenkel, Tobias
    Lam, Annette
    He, Jianming
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (06) : 443 - 455
  • [3] Using Patient Preferences to Determine Noninferiority Margins in Trials
    Feuer, Eric J.
    Jagsi, Reshma
    Lansdorp-Vogelaar, Iris
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2137 - 2138
  • [4] The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents
    Powers, JH
    Ross, DB
    Brittain, E
    Albrecht, R
    Goldberger, MJ
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) : 879 - 881
  • [5] Noninferiority trials in clinical practice
    Marko, Monika
    Pawliczak, Rafal
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2019, 6 (04) : 152 - 159
  • [6] The Clinical Interpretation of Noninferiority Trials
    Roshanov, Pavel S.
    Khanna, Reena
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (11) : 2191 - 2194
  • [7] Principles for Defining Estimands in Clinical Trials-A Proposal
    Mutze, Tobias
    Bell, James
    Englert, Stefan
    Hougaard, Philip
    Jackson, Dan
    Lanius, Vivian
    Ravn, Henrik
    PHARMACEUTICAL STATISTICS, 2025, 24 (01)
  • [8] Hazard ratios in cancer clinical trials-a primer
    Blagoev, Krastan B.
    Wilkerson, Julia
    Fojo, Tito
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (03) : 178 - 183
  • [9] Using Patient Preferences to Determine Noninferiority Margins in Trials Reply
    Acuna, Sergio A.
    Chesney, Tyler R.
    Baxter, Nancy N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2138 - 2138
  • [10] Secondary Analysis of Clinical Trials-A Cautionary Note
    Marler, John R.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (04) : 335 - 337
12345